Study Overview: This study tests a new treatment for diabetic foot ulcers (DFUs), which are sores on the feet that can be hard to heal in people with diabetes. The trial will compare how well a special amniotic membrane (Artacent®) works along with regular care versus just regular care by itself. The study will last about 12 months.

Key Points:

• Study Duration: Participation involves attending weekly visits for up to 12 months.
• Eligibility: Must be at least 18, have diabetes, and a specific type of foot ulcer. Some health conditions may make you ineligible.
• Compensation: Check with the study coordinator for details on compensation for participation.

Eligibility Details: To join, you need to be an adult with type 1 or type 2 diabetes and have a specific kind of foot ulcer. Your ulcer should be of a certain size and not infected. Certain health issues, like severe infections or recent use of some medications, might disqualify you. Pregnant women or those planning to become pregnant soon cannot join. Participants need to follow study guidelines, which may include using special shoes or walking aids to help their feet heal.